muscarinic M3 antagonists (Almirall)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namemuscarinic M3 antagonists (Almirall)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists

TargetsMuscarinic acetylcholine receptor M3

Therapy Area/IndicationsAsthmaBronchitis, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlmirall Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlmirall Sa

Active IndicationsN/A

Inactive IndicationsAsthmaBronchitis, Chronic

ATC CodeN/A